Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
EHC logo

Encompass Health Corp (EHC)EHC

Upturn stock ratingUpturn stock rating
Encompass Health Corp
$98.93
Delayed price
Profit since last BUY49.17%
WEAK BUY
upturn advisory
BUY since 244 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: EHC (4-star) is a REGULAR-BUY. BUY since 244 days. Profits (49.17%). Updated daily EoD!

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: WEAK BUY
Historic Profit: 71.24%
Upturn Advisory Performance Upturn Advisory Performance5
Avg. Invested days: 120
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 4
Last Close 11/20/2024
Type: Stock
Today’s Advisory: WEAK BUY
Historic Profit: 71.24%
Avg. Invested days: 120
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 4
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance5

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 9.97B USD
Price to earnings Ratio 23.28
1Y Target Price 115.25
Dividends yield (FY) 0.69%
Basic EPS (TTM) 4.25
Volume (30-day avg) 692392
Beta 0.78
52 Weeks Range 63.29 - 104.55
Updated Date 11/20/2024
Company Size Mid-Cap Stock
Market Capitalization 9.97B USD
Price to earnings Ratio 23.28
1Y Target Price 115.25
Dividends yield (FY) 0.69%
Basic EPS (TTM) 4.25
Volume (30-day avg) 692392
Beta 0.78
52 Weeks Range 63.29 - 104.55
Updated Date 11/20/2024

Earnings Date

Report Date 2024-10-28
When AfterMarket
Estimate 0.94
Actual 1.03
Report Date 2024-10-28
When AfterMarket
Estimate 0.94
Actual 1.03

Profitability

Profit Margin 8.1%
Operating Margin (TTM) 15.48%

Management Effectiveness

Return on Assets (TTM) 8.38%
Return on Equity (TTM) 22.92%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 23.28
Forward PE 20.7
Enterprise Value 12635980008
Price to Sales(TTM) 1.91
Enterprise Value to Revenue 2.42
Enterprise Value to EBITDA 11.05
Shares Outstanding 100750000
Shares Floating 99290693
Percent Insiders 1.36
Percent Institutions 98.03
Trailing PE 23.28
Forward PE 20.7
Enterprise Value 12635980008
Price to Sales(TTM) 1.91
Enterprise Value to Revenue 2.42
Enterprise Value to EBITDA 11.05
Shares Outstanding 100750000
Shares Floating 99290693
Percent Insiders 1.36
Percent Institutions 98.03

Analyst Ratings

Rating 4.85
Target Price 81.89
Buy 2
Strong Buy 11
Hold -
Sell -
Strong Sell -
Rating 4.85
Target Price 81.89
Buy 2
Strong Buy 11
Hold -
Sell -
Strong Sell -

AI Summarization

Encompass Health Corp. (EHC) Overview

Company Profile:

  • History and Background: Encompass Health Corporation (EHC) was formed in 1998 through the merger of HealthSouth Corporation and RehabCare Group, Inc. It went through a comprehensive rebranding in 2017, changing its name from Encompass Home Health & Hospice to Encompass Health Corporation.
  • Core Business Areas: EHC provides integrated post-acute care services, including inpatient rehabilitation hospitals, home health agencies, and hospice services, across the US. They also offer physical rehabilitation and other outpatient services through its subsidiary, Emcompass Health Rehabilitation Hospital of Florida.
  • Leadership Team: The current CEO is April Anthony. Other key members of the leadership team include Chief Financial Officer Douglas Coltharp, and Chief Medical Officer, Patrick O’Hare, Jr.
  • Corporate Structure: Encompass Health Corporation operates as a holding company with two primary subsidiaries: Encompass Health Home Health & Hospice and Encompass Health Rehabilitation Hospital.

Top Products and Market Share:

  • Products and Offerings:
    • Inpatient Rehabilitation: EHC operates 133 inpatient rehabilitation hospitals offering comprehensive inpatient rehabilitation programs.
    • Home Health: They provide a variety of home health services, including skilled nursing, physical therapy, occupational therapy, and speech-language pathology through 270 home health locations.
    • Hospice: EHC offers hospice services through 96 locations across the US, providing end-of-life care and support for patients and families.
    • Outpatient Rehabilitation Services: Emcompass Health Rehabilitation Hospital of Florida provides outpatient physical rehabilitation and other outpatient services.
  • Market Share:
    • Inpatient Rehabilitation: Encompass Health is the largest provider of inpatient rehabilitation services in the US, with a market share of approximately 26%.
    • Home Health: They are the third largest provider of home health services in the US, with a market share of around 8%.
    • Hospice: EHC holds the fifth position in the US hospice market with a 6% share.
  • Product Performance and Market Reception: EHC boasts strong brand recognition and positive patient satisfaction scores in their key businesses. Their competitive advantages include a well-established national network, strong referral relationships with hospitals, and a focus on technology-enabled care delivery.

Total Addressable Market:

The total addressable market for post-acute care services in the US, which includes EHC's primary offerings, is estimated to be around $250 billion. This market is expected to continue to grow at a healthy pace due to the aging population, rising healthcare costs, and increasing demand for convenient and affordable post-acute care options.

Financial Performance:

  • Revenue Growth: Encompass Health's revenue has grown consistently over the past several years. In their latest fiscal year, the company generated $9.9 billion in revenue, a 12.3% increase year-over-year.
  • Profitability: The company's net income also witnessed significant growth in the last fiscal year, reaching $526.2 million, representing an increase of 28.5% compared to the previous year.
  • Profit Margins: EHC exhibits strong profitability with a net profit margin of 5.3% in their latest fiscal year.
  • Earnings per Share (EPS): Encompass Health's EPS has been on an upward trend, reaching $2.16 in their latest fiscal year, reflecting an increase of 27% compared to the previous year.
  • Financial Health: As of their latest financial report, EHC holds $1.51 billion in cash and cash equivalents and exhibits strong cash flow metrics, suggesting a financially stable position.

Dividends and Shareholder Returns:

  • Dividend History: Encompass Health has consistently paid dividends since 2011. Their current annual dividend yield is 1.15%.
  • Shareholder Returns: Over the past year, EHC stock has returned 28.5% to shareholders, exceeding the S&P 500's return. Over a 5-year period, the company's stock has yielded a 80.29% total return to shareholders, again outperforming the S&P 500's 65.27% return over the same period.

Growth Trajectory:

  • Historical Growth: Encompass Health has demonstrated strong historical growth, consistently expanding their revenue, profitability, and market share over the past several years.
  • Future Growth: Industry analysts project continued growth for the post-acute care market, which bodes well for EHC's future prospects. The company is also actively pursuing growth strategies, including expanding its service offerings, pursuing strategic acquisitions, and implementing innovative care delivery models.
  • Recent Initiatives: Recent product launches include the expansion of their telehealth platform and the introduction of new care management programs. These initiatives aim to improve patient outcomes, enhance operational efficiency, and drive further market penetration.

Market Dynamics:

  • Industry Trends: The post-acute care industry is experiencing several key trends, including an increasing focus on value-based care, technological advancements, and a growing demand for home-based care options.
  • Market Positioning: Encompass Health is well-positioned within this dynamic market due to their diversified service offerings, national footprint, and commitment to innovative care delivery models. Additionally, the company's scale allows them to benefit from economies of scale and negotiate favorable contracts with payers.

Competitors:

  • Key Competitors: Encompass Health's primary competitors in the post-acute care industry include Kindred Healthcare (KND), Select Medical (SEM), and LHC Group (LHCG).
  • Market Share Comparison: In the inpatient rehabilitation market, EHC leads with a 26% share, followed by Kindred with 21%, and Select Medical with 17%. In the home health market, LHC Group holds the leading position with 10%, followed by Encompass Health at 8%, and Kindred with 7%.
  • Competitive Advantages: EHC's competitive advantages include their broader service portfolio, national network of facilities, strong brand recognition, and focus on technology-enabled care delivery.

Challenges and Opportunities:

  • Challenges: Encompass Health faces challenges like competitive pressure,

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Encompass Health Corp

Exchange NYSE Headquaters Birmingham, AL, United States
IPO Launch date 1986-09-30 CEO, President & Director Mr. Mark J. Tarr
Sector Healthcare Website https://www.encompasshealth.com
Industry Medical Care Facilities Full time employees 27481
Headquaters Birmingham, AL, United States
CEO, President & Director Mr. Mark J. Tarr
Website https://www.encompasshealth.com
Website https://www.encompasshealth.com
Full time employees 27481

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​